Analyst Recommendations

Barclays analyst issues OVERWEIGHT recommendation for AMD on March 4, 2024 07:56AM ET. The previous analyst recommendation was Overweight.AMD was trading at $202.64 at issue of the analyst...

March 4, 2024   AMD -4.68%

Bank of America Securities analyst issues BUY recommendation for LLY on March 1, 2024 03:44PM ET. The previous analyst recommendation was Buy.LLY was trading at $782.24 at issue...

March 1, 2024   LLY 1.61%

Truist Financial analyst issues UNDERPERFORM recommendation for PFE on March 1, 2024 10:00AM ET. The previous analyst recommendation was Underperform.PFE was trading at $26.61 at issue of the...

March 1, 2024   PFE -0.52%

UBS analyst issues MARKET PERFORM recommendation for PFE on March 1, 2024 10:00AM ET. The previous analyst recommendation was Market Perform.PFE was trading at $26.61 at issue of...

March 1, 2024   PFE -0.52%

RBC Capital analyst issues UNDERPERFORM recommendation for UNH on February 29, 2024 02:00PM ET. The previous analyst recommendation was Underperform.UNH was trading at $492.51 at issue of the...

February 29, 2024   UNH -0.79%

Stephens analyst issues OUTPERFORM recommendation for UNH on February 29, 2024 02:00PM ET. The previous analyst recommendation was Outperform.UNH was trading at $492.51 at issue of the analyst...

February 29, 2024   UNH -0.79%

Piper Sandler analyst issues NEUTRAL recommendation for CRM on February 29, 2024 11:31AM ET. The previous analyst recommendation was Neutral.CRM was trading at $303.26 at issue of the...

February 29, 2024   CRM -2.76%

JMP Securities analyst issues MARKET PERFORM recommendation for CRM on February 29, 2024 11:31AM ET. The previous analyst recommendation was Market Perform.CRM was trading at $303.26 at issue...

February 29, 2024   CRM -2.76%

Tigress Financial analyst issues BUY recommendation for NVDA on February 29, 2024 10:40AM ET. The previous analyst recommendation was Buy.NVDA was trading at $790.69 at issue of the...

February 29, 2024   NVDA -2.89%

UBS analyst issues OUTPERFORM recommendation for CRM on February 29, 2024 10:40AM ET. The previous analyst recommendation was Outperform.CRM was trading at $303.75 at issue of the analyst...

February 29, 2024   CRM -2.76%